Fusion Pharmaceuticals (FUSN) Jumps: Stock Rises 9%
Fusion Pharmaceuticals Inc. FUSN was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $12.35 –$13.73 in the past one-month time frame, witnessed a sharp increase yesterday.
The company has seen a mixed track record when it comes to estimate revision of one increase and two decreases over the past few weeks, while the Zacks Consensus Estimate for the current quarter has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Fusion Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Fusion Pharmaceuticals Inc. Price
Fusion Pharmaceuticals Inc. price | Fusion Pharmaceuticals Inc. Quote
Investors interested in the Medical - Drugs industry may consider BioLineRx Ltd. BLRX, which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BioLineRx Ltd. (BLRX) : Free Stock Analysis Report
Fusion Pharmaceuticals Inc. (FUSN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
